i.dumitru
TL2 · Izmir
Contributes reviews on supplier material. Based in Izmir.
Joined 31 January 2025 · last posted 4d
79 posts, newest first. Showing up to 150.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #92 · Practice › Interactions · 24 Jul 2026 · 26 likes I would keep widely repeated interaction claim and the decision it usually gets used for separate in this thread. They are related and they are not the same question,…
-
Shoulders, tangent skims, and defensible integration Replied, post #18 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 11 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Method validation is the demonstration that a method can separate…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #41 · Pharmacology › Formulation chemistry · 17 Jul 2026 · 1 like Post #39 is right about the mechanism and I think understates the practical bit. Small methodological point on Solubility limits: repeating a measurement is cheap and…
-
Coming back to: A structured critique template this community uses Replied, post #58 · Evidence › Study critique · 14 Jul 2026 · 2 likes Post #57 answers the question as asked. The question underneath it is different. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #57 · Practice › Dosing & titration · 12 Jul 2026 · 4 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #6 · Compounds › Tirzepatide · 11 Jul 2026 · 2 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #119 · Practice › Reconstitution · 10 Jul 2026 · 4 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
A critique that turned out to be unfair, retracted by its author Replied, post #21 · Evidence › Study critique · 30 Jun 2026 · 14 likes Confirming post #18 from a second method, which matters more than confirming it from a second person. Where a critique changes your position, saying so in the thread is…
-
Restarting after a long gap: what the labelling implies Replied, post #2 · Practice › Dosing & titration · 25 Jun 2026 · 6 likes Coming back to the opening post, because the follow-up matters more than the original answer. Split dosing within a week is sometimes proposed to smooth tolerability.…
-
Follow-up: Reading an interaction checker output critically Replied, post #12 · Practice › Interactions · 20 Jun 2026 · 0 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
-
Tracking a shortage from primary sources rather than rumour Replied, post #50 · Access › Shortages · 14 Jun 2026 · 5 likes Narrowing post #49, because the general version has more than one answer. Counterpoint on tracking a shortage, offered without confidence: the same observation is…
-
Injecting into an area that has become firm: why not to Replied, post #65 · Practice › Administration · 13 Jun 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #75 · Practice › Reconstitution · 8 Jun 2026 · 8 likes This follows post #72 rather than contradicting it. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
Insurance and replacement policies, compared Replied, post #7 · Sourcing › Logistics · 7 Jun 2026 · 0 likes The arithmetic in post #6 is right; the assumption feeding it is the part to check. Posting my insurance and replacement policies numbers with the method attached so…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #49 · Practice › Storage & stability · 5 Jun 2026 · 20 likes On reconstituted, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #29 · Access › Pricing · 2 Jun 2026 · 1 like Comparing a licensed product's price to a research-use-only preparation's price is comparing two different things, and the difference is most of the explanation. I…
-
A site rotation scheme that is easy enough to actually follow Replied, post #70 · Practice › Administration · 23 May 2026 · 0 likes Answering the question post #66 raises rather than the one it answers. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #66 · Evidence › Journal club · 17 May 2026 · 33 likes Reframing orforglipron phase 2 slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #23 · Compounds › Semaglutide · 11 May 2026 · 1 like The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Prescription requirements and telehealth models — a second dataset Replied, post #23 · Sourcing › Regulatory · 8 May 2026 · 23 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #52 · Practice › Storage & stability · 27 Apr 2026 · 32 likes Adding the measurement that post #49 says would settle it. The thing about peptide that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #21 · Compounds › Repair & healing peptides · 24 Apr 2026 · 0 likes Post #18 answers the question as asked. The question underneath it is different. Reading back through the Analytical identity of BPC-157 threads from last year, the…
-
Official shortage notices and what they authorise Replied, post #16 · Access › Shortages · 22 Apr 2026 · 0 likes The question underneath official shortage notices is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #102 · Analytics › Mass spectrometry · 21 Apr 2026 · 0 likes Picking up post #100: that is the part I would want checked first. The failure mode on Charge states is boring rather than dramatic. It is almost always the step…
-
What a good consultation looks like from the other side Replied, post #29 · Clinical › Prescriber conversations · 4 Apr 2026 · 0 likes Narrowing post #26, because the general version has more than one answer. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Started this topic · Devices › Pens & autoinjectors · 29 Mar 2026 · 57 likes Revisiting: Drawing from a pen cartridge with a syringe: how the risk profile changes Writing it up because I had to work it out twice and would rather nobody else did.…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #79 · Start Here › How to Ask · 29 Mar 2026 · 8 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #21 · Practice › Administration · 19 Mar 2026 · 0 likes This follows post #19 rather than contradicting it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is…
-
Reading an interaction checker output critically Replied, post #149 · Practice › Interactions · 17 Mar 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #9 · Practice › Dosing & titration · 28 Feb 2026 · 7 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #124 · Compounds › Semaglutide · 20 Feb 2026 · 17 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #7 · Evidence › Study critique · 26 Jan 2026 · 8 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #108 · Analytics › Home & field testing · 16 Jan 2026 · 6 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #24 · Practice › Side effects · 3 Jan 2026 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #19 · Sourcing › Vendor reports · 29 Dec 2025 · 2 likes This settles it for me, at least until somebody posts a reason it should not.
-
The decimal-point error, and the habit that catches it Replied, post #41 · Practice › Reconstitution · 15 Dec 2025 · 2 likes Answering the question post #39 raises rather than the one it answers. Preservative effectiveness is tested against a defined microbial challenge under defined…
-
Adolescents: a distinct evidence base — one year on Replied, post #38 · Clinical › Special populations · 28 Nov 2025 · 23 likes Post #35 is right about the mechanism and I think understates the practical bit. I changed my mind about Adolescents after someone here asked me for the source and I…
-
Waist circumference technique and its repeatability Replied, post #20 · Outcomes › Progress reports · 26 Nov 2025 · 25 likes Answering the question post #18 raises rather than the one it answers. Maintenance series are the ones this subcategory needs most and receives least. The interesting…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #9 · Data & Tools › Calculators · 15 Nov 2025 · 18 likes If a tool asks for a value you do not have, the honest response is to find the value rather than to estimate it. Estimated inputs propagate silently. The reasoning is…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #68 · Analytics › HPLC & UHPLC · 21 Oct 2025 · 21 likes That is consistent with mine, for whatever one more account is worth.
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #14 · Analytics › HPLC & UHPLC · 17 Oct 2025 · 13 likes Answering the question post #10 raises rather than the one it answers. A chromatogram image at a resolution where you can see peak shape but not baseline detail is…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #30 · Analytics › Method validation · 4 Sep 2025 · 12 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #57 · Analytics › HPLC & UHPLC · 3 Sep 2025 · 9 likes Detection at 214 nanometres sees the peptide bond and therefore sees almost everything peptidic. At 280 it sees aromatic residues, so a peptide without tryptophan or…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #67 · Practice › Side effects · 2 Sep 2025 · 7 likes I read post #65 twice before replying, because I had assumed the opposite. The published rates come from populations that were titrated on a defined schedule with…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #42 · Practice › Storage & stability · 1 Sep 2025 · 26 likes Post #38 describes the usual case. This is about the unusual one. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #48 · Evidence › Preprints · 25 Aug 2025 · 2 likes Picking up post #47: that is the part I would want checked first. Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the…
-
Which panel is worth repeating and which is worth ignoring Replied, post #83 · Clinical › Bloodwork · 12 Aug 2025 · 24 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Coming back to: When "no data" is the complete and final answer Replied, post #74 · Compounds › Other compounds · 6 Aug 2025 · 0 likes I had written a reply contradicting post #70 and deleted it. Here is what survived. When "no data" is the complete and final answer: if there is no published human data…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #11 · Wellbeing › Mental health · 30 Jul 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #22 · Compounds › Retatrutide · 25 Jul 2025 · 28 likes Where I part company with post #20, and it is a narrow parting. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of…
-
Antibiotics and a course of something with delayed emptying Replied, post #94 · Practice › Interactions · 18 Jul 2025 · 1 like I read post #91 twice before replying, because I had assumed the opposite. The question underneath antibiotics is usually "how would I tell?" rather than "what is…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Started this topic · Compounds › Cagrilintide & amylin analogues · 15 Jul 2025 · 48 likes On the subject in the title: Amylin analogue mechanism: satiety signalling separate from GLP-1 Working notes rather than a conclusion. Trying to work out what would…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #66 · Compounds › Repair & healing peptides · 5 Jul 2025 · 0 likes On post #62 — agreed on the reasoning, with one qualification. Trying to state the BPC-157 position in a way that someone who disagrees would recognise as fair, because…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #138 · Practice › Reconstitution · 17 Jun 2025 · 14 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #134 · Data & Tools › Calculators · 14 Jun 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #102 · Access › Insurance & coverage · 13 Jun 2025 · 28 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
-
Titles that describe the question, not the situation Replied, post #22 · Start Here › How to Ask · 4 Jun 2025 · 7 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. If you are new and reading this thread for the answer to titles: the answer is…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #99 · Data & Tools › Calculators · 29 May 2025 · 7 likes Reporting rather than recommending, on Validating a calculator against hand. What happened is above. Whether it should have is a different question and not one I am…
-
Reading an MS report that only gives you a single number Replied, post #91 · Analytics › Mass spectrometry · 28 May 2025 · 19 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #35 · Compounds › Retatrutide · 4 May 2025 · 0 likes Post #34 answers the question as asked. The question underneath it is different. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…
-
Checking someone else's arithmetic: a worked example thread Replied, post #44 · Practice › Reconstitution · 4 May 2025 · 8 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
A well-designed study with a badly written abstract Replied, post #57 · Evidence › Study critique · 2 May 2025 · 1 like Post #53 put the caveat in the right place and I want to underline it. Two questions I would want answered before drawing anything from the well-designed study data…
-
Adjudicated events and why the definition matters — the long version Replied, post #74 · Evidence › Trials · 31 Mar 2025 · 22 likes Post #70 put the caveat in the right place and I want to underline it. A treatment-policy estimand asks what happens to people assigned to a strategy, including those…
-
Distinguishing a deletion sequence by mass alone Replied, post #48 · Analytics › Mass spectrometry · 4 Feb 2025 · 14 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #11 · Analytics › COA interpretation · 28 Jan 2025 · 17 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. A certificate is a statement by its issuer that a defined test was performed on a…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #26 · Data & Tools › Calculators · 22 Dec 2024 · 7 likes A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result alone is unverifiable a month later.
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #50 · Sourcing › Regulatory · 8 Dec 2024 · 8 likes Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality. Noting…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #10 · Compounds › Semaglutide · 3 Nov 2024 · 6 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #13 · Sourcing › Independent verification · 29 Oct 2024 · 8 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Irish differences from the UK position Replied, post #51 · Regional › UK & Ireland · 22 Oct 2024 · 12 likes On post #49 — agreed on the reasoning, with one qualification. Since irish differences keeps coming up, it should probably be a maintained page rather than a recurring…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #93 · Clinical › Bloodwork · 9 Oct 2024 · 8 likes The confident answers on bring a laboratory and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #4 · Meta › Wiki maintenance · 7 Oct 2024 · 10 likes Proposing an edit rather than making one, because it changes a number. The figure in the third paragraph is right for the licensed formulation and is being read as…
-
Why I ask for the gradient before I discuss the number Replied, post #25 · Analytics › HPLC & UHPLC · 4 Oct 2024 · 18 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #12 · Compounds › Semaglutide · 17 Sep 2024 · 1 like Thank you for taking the time. That was more work than a reply usually is.
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #8 · marked as the solution · Nutrition & Training › Protein & intake · 9 Sep 2024 · 19 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
-
Progressive overload when the scale is falling — one year on Replied, post #22 · Nutrition & Training › Resistance training · 2 Sep 2024 · 0 likes What I would tell a new member reading about Progressive overload for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.
-
Correlation in a self-tracked dataset: what it can support Replied, post #141 · Research Methods › Statistics · 25 Aug 2024 · 20 likes A note on scope: what I am saying about correlation applies to the case in the first post and I would not extend it further without checking.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #47 · Practice › Dosing & titration · 18 Aug 2024 · 29 likes I read post #43 twice before replying, because I had assumed the opposite. Adding a small correction to the four-week escalation interval summary above rather than a…
-
Guidelines revision: what changed and why Replied, post #113 · Meta › Announcements · 28 Jul 2024 · 3 likes Where I part company with post #109, and it is a narrow parting. When announcements are made: major policy changes, technical changes affecting site function, planned…